Literature DB >> 28681589

Toxic epidermal necrolysis after dactinomycin and vincristine combination chemotherapy for nephroblastoma.

Yuan Liang1, Zhou Yang1, Zi-Gang Xu1, Lin Ma1.   

Abstract

In this study, we describe a 2-year-old boy patient with nephroblastoma who has developed toxic epidermal necrolysis (TEN) associated with the combination chemotherapy administration of dactinomycin and vincristine. A skin biopsy confirmed the diagnosis of TEN, and with methylprednisolone pulse therapy, intravenous immunoglobulin (IVIG), and supportive care, the patient improved significantly.

Entities:  

Keywords:  Drug reaction; Malignant neoplasms; Toxic epidermal necrolysis; Chemotherapy; Nephroblastoma

Mesh：

Substances：

Year:  2017        PMID： 28681589      PMCID： PMC5498845          DOI： 10.1631/jzus.B1700065

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN： 1673-1581            Impact factor:   3.066


  10 in total

Review 1.  Stevens-Johnson syndrome and toxic epidermal necrolysis: oncologic considerations.

Authors:  Keri Cassidy Hockett
Journal:  Clin J Oncol Nurs       Date:  2004-02       Impact factor: 1.027

2.  Toxic epidermal necrolysis and Steven-Johnson syndrome in oncologic patients.

Authors:  G Gravante; D Delogu; M Marianetti; G Esposito; A Montone
Journal:  Eur Rev Med Pharmacol Sci       Date:  2007 Jul-Aug       Impact factor: 3.507

3.  Toxic epidermal necrolysis after PCV combination chemotherapy for relapsed B-cell lymphoma.

Authors:  R Jones; M Kirkup; S Guglani; K Hopkins
Journal:  Clin Oncol (R Coll Radiol)       Date:  2006-02       Impact factor: 4.126

Review 4.  Toxic epidermal necrolysis: Part I. Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis.

Authors:  Robert A Schwartz; Patrick H McDonough; Brian W Lee
Journal:  J Am Acad Dermatol       Date:  2013-08       Impact factor: 11.527

5.  [Stevens-Johnson syndrome and Hodgkin's disease: A fortuitous association or paraneoplastic syndrome?].

Authors:  A Schoeffler; E Levy; M Weinborn; J-F Cuny; J-L Schmutz; A Barbaud; B Cribier; A-C Bursztejn
Journal:  Ann Dermatol Venereol       Date:  2013-12-12       Impact factor: 0.777

Review 6.  Severe cutaneous adverse drug reactions.

Authors:  Wen-Hung Chung; Chuang-Wei Wang; Ro-Lan Dao
Journal:  J Dermatol       Date:  2016-05-06       Impact factor: 4.005

7.  Toxic epidermal necrolysis following combination of methotrexate and trimethoprim-sulfamethoxazole.

Authors:  C H Yang; L J Yang; T H Jaing; H L Chan
Journal:  Int J Dermatol       Date:  2000-08       Impact factor: 2.736

8.  [A Case of Stevens-Johnson Syndrome Developing during Chemoradiotherapy for Maxillary Sinus Cancer].

Authors:  Kousuke Yoshifuku; Kengo Nishimoto; Tsutomu Matsuzaki; Shigeto Matsushita
Journal:  Nihon Jibiinkoka Gakkai Kaiho       Date:  2015-12

9.  Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with malignancies.

Authors:  J Wu; Y Y Lee; S C Su; T S Wu; K C Kao; C C Huang; W C Chang; C H Yang; W H Chung
Journal:  Br J Dermatol       Date:  2015-10-19       Impact factor: 9.302

10.  Stevens-Johnson Syndrome Patient Received Combination Chemotherapy Gemcitabine, Cisplatin, and 5-FU for Biliary Tract Cancer.

Authors:  Mozaffar Aznab; Mansour Khazaei
Journal:  Iran J Cancer Prev       Date:  2016-06-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.